Development of Medical Lasers for Treatment on Benign Prostatic Hyperplasia

被引：0

作者：

Xiao-Lei Ren ^{[1
]}

Hai-Bo Xia ^{[1
]}

机构：

[1] Department of Urology,The Second Affiliated Hospital of Chifeng College

来源：

中华医学杂志(英文版) | 2018年 / 131卷 / 18期

关键词：

D O I：

暂无

中图分类号：

R697.3 [];

学科分类号：

1002 ; 100210 ;

摘要：

Benign prostatic hyperplasia(BPH) is one of the most common causes of lower urinary tract symptoms in aged males. Many patients with BPH may go on to require surgical intervention.At present, transurethral resection of the prostate(TURP) is the gold standard for BPH treatment owing to its minimal damage,low cost, and long-term efficacy. However, many complications associated with TURP represent major drawbacks of this procedure. These complications include hemorrhage, perforation

引用

页码：2265 / 2268

页数：4

共 50 条

[41] Prostatic stents for the treatment of benign prostatic hyperplasia
VanderBrink, Brian A.
Rastinehad, Ardeshir R.
Badlani, Gopal H.
[J]. CURRENT OPINION IN UROLOGY, 2007, 17 (01) : 1 - 6
[42] Different lasers in the treatment of benign prostatic hyperplasia: a network meta-analysis
Zhang, Xingming
Shen, Pengfei
He, Qiying
Yin, Xiaoxue
Chen, Zhibin
Gui, Haojun
Shu, Kunpeng
Tang, Qidun
Yang, Yaojing
Pan, Xiuyi
Wang, Jia
Chen, Ni
Zeng, Hao
[J]. SCIENTIFIC REPORTS, 2016, 6
[43] Different lasers in the treatment of benign prostatic hyperplasia: a network meta-analysis
Xingming Zhang
Pengfei Shen
Qiying He
Xiaoxue Yin
Zhibin Chen
Haojun Gui
Kunpeng Shu
Qidun Tang
Yaojing Yang
Xiuyi Pan
Jia Wang
Ni Chen
Hao Zeng
[J]. Scientific Reports, 6
[44] Critical review of lasers in benign prostatic hyperplasia (BPH)
Gravas, Stavros
Bachmann, Alexander
Reich, Oliver
Roehrborn, Claus G.
Gilling, Peter J.
De La Rosette, Jean
[J]. BJU INTERNATIONAL, 2011, 107 (07) : 1030 - 1043
[45] Advances in the development of hormonal modulators for the treatment of benign prostatic hyperplasia
Tiwari, Atul
[J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (09) : 1425 - 1439
[46] Trends in the development of new drugs for treatment of benign prostatic hyperplasia
Kulig, Katarzyna
Malawska, Barbara
[J]. CURRENT MEDICINAL CHEMISTRY, 2006, 13 (28) : 3395 - 3416
[47] HEALTH CARE DISPARITIES IN MEDICAL AND SURGICAL TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
Mithal, Alka
Singh, Gurkirpal
Mannalithara, Ajitha
Malani, Rachna
Triadafilopoulos, George
Gill, Harcharan
[J]. JOURNAL OF UROLOGY, 2010, 183 (04): : E694 - E694
[48] Medical treatment for benign prostatic hyperplasia: Where do we stand?
Rossanese, Marta
Crestani, Alessandro
Inferrera, Antonino
Giannarini, Gianluca
Bartoletti, Riccardo
Tubaro, Andrea
Ficarra, Vincenzo
[J]. UROLOGIA JOURNAL, 2019, 86 (03) : 115 - 121
[49] Impact of Metabolic Syndrome on Response to Medical Treatment of Benign Prostatic Hyperplasia
Cyrus, Ali
Kabir, Ali
Goodarzi, Davood
Talaei, Afsaneh
Moradi, Ali
Rafiee, Mohammad
Moghimi, Mehrdad
Shahbazi, Elham
Farmani, Elaheh
[J]. KOREAN JOURNAL OF UROLOGY, 2014, 55 (12) : 814 - 820
[50] Medical treatment of benign prostatic hyperplasia: physician and patient preferences and satisfaction
Emberton, M.
[J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (10) : 1425 - 1435

← 1 2 3 4 5 →